Primary Generalized Glucocorticoid Resistance Syndrome.
Kino T, Nicolaides NC, Charmandari E, Chrousos GP.
2024 May 19. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Adrenocorticotropic hormone: An expansion of our current understanding of the treatment for nephrotic syndrome.
Hu D, Li J, Zhuang Y, Mao X.
Steroids. 2021 Dec;176:108930. doi: 10.1016/j.steroids.2021.108930. Epub 2021 Oct 11.
Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome.
Wang Y, Dang X, Wu X, Li Y, He Q, Li X.
Front Pediatr. 2023 Mar 9;11:1044075. doi: 10.3389/fped.2023.1044075. eCollection 2023.
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH).
Bomback AS, Radhakrishnan J.
Discov Med. 2011 Aug;12(63):91-6.
The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing's Disease.
Fukuoka H, Shichi H, Yamamoto M, Takahashi Y.
Int J Mol Sci. 2020 Nov 30;21(23):9132. doi: 10.3390/ijms21239132.
Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance.
Lieberman KV, Pavlova-Wolf A.
J Nephrol. 2017 Feb;30(1):35-44. doi: 10.1007/s40620-016-0308-3. Epub 2016 Apr 16.
GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome.
Vitellius G, Lombes M.
Eur J Endocrinol. 2020 Feb 1;182(2):R15-R27. doi: 10.1530/EJE-19-0811.
Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.
Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND.
Surgery. 2022 Aug;172(2):559-566. doi: 10.1016/j.surg.2022.03.014. Epub 2022 Apr 16.
Adrenocorticotropic hormone analog use for podocytopathies.
Filippone EJ, Dopson SJ, Rivers DM, Monk RD, Udani SM, Jafari G, Huang SC, Melhem A, Assioun B, Schmitz PG.
Int Med Case Rep J. 2016 Jun 28;9:125-33. doi: 10.2147/IMCRJ.S104899. eCollection 2016.
Triple-A syndrome.
Sarathi V, Shah NS.
Adv Exp Med Biol. 2010;685:1-8. doi: 10.1007/978-1-4419-6448-9_1.
